Suppression of store-operated Ca2+ entry regulated by silencing Orai1 inhibits C6 glioma cell motility via decreasing Pyk2 activity and promoting focal adhesion
- PMID: 33269647
- PMCID: PMC7781592
- DOI: 10.1080/15384101.2020.1843814
Suppression of store-operated Ca2+ entry regulated by silencing Orai1 inhibits C6 glioma cell motility via decreasing Pyk2 activity and promoting focal adhesion
Abstract
Store-operated Ca2+ entry (SOCE) plays an important role in regulating Ca2+ influx, which participates in tumor cell survival and motility. We aim to elucidate the role of SOCE in the behavior of C6 glioma cells. Lentiviral vector inserted with the Orai1-targeting shRNA was used to inhibit SOCE in C6 glioma cells. The down-regulation of Orai1 was confirmed by western blot. The ability of shOrai1 or SOCE inhibitor (SKF96365) in regulating SOCE inhibition was evaluated by measuring Ca2+ concentration. Additionally, its effect on cell behavior was assessed using methyl thiazolyl tetrazolium (MTT) assay, wound healing assay, transwell assay, and adhesion assay. Focal adhesions were visualized by immunofluorescence assay. Further, the expression of proline-rich tyrosine kinase 2 (Pyk2) and phosphorylated Pyk2 (p-Pyk2) was analyzed using western blot. Both, SKF96365 treatment and the Orai1 down-regulation inhibited SOCE by perturbing Ca2+ influx. The inhibitory effects of shOrai1 on C6 cell proliferation, migration, and invasion were similar to that of SKF96365. Moreover, Orai1 inhibition enhanced C6 cell adhesion by increasing the size of focal adhesion plaques. The down-regulation of Pyk2 was observed in both SKF96365-treated and Orai1-silenced C6 cells. Additionally, Orai1 inhibition blocked AKT/mTOR, NFAT, and NF-κB pathways. The silencing of Orai1 inhibited the C6 glioma cell migration, invasion and contributed to focal adhesion.
Keywords: Store-operated Ca2+ entry; calcium release-activated calcium channel protein1; cell adhesion; glioma; proline-rich tyrosine kinase 2.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
Store-operated Ca(2+) entry regulates glioma cell migration and invasion via modulation of Pyk2 phosphorylation.J Exp Clin Cancer Res. 2014 Nov 30;33(1):98. doi: 10.1186/s13046-014-0098-1. J Exp Clin Cancer Res. 2014. PMID: 25433371 Free PMC article.
-
Induction of proline-rich tyrosine kinase 2 activation-mediated C6 glioma cell invasion after anti-vascular endothelial growth factor therapy.J Transl Med. 2014 May 27;12:148. doi: 10.1186/1479-5876-12-148. J Transl Med. 2014. PMID: 24884636 Free PMC article.
-
Imaging elemental events of store-operated Ca2+ entry in invading cancer cells with plasmalemmal targeted sensors.J Cell Sci. 2019 Mar 25;132(6):jcs224923. doi: 10.1242/jcs.224923. J Cell Sci. 2019. PMID: 30814332 Free PMC article.
-
Store Operated Calcium Entry in Cell Migration and Cancer Metastasis.Cells. 2021 May 19;10(5):1246. doi: 10.3390/cells10051246. Cells. 2021. PMID: 34069353 Free PMC article. Review.
-
Fine-tuning of store-operated calcium entry by fast and slow Ca2+-dependent inactivation: Involvement of SARAF.Biochim Biophys Acta Mol Cell Res. 2018 Mar;1865(3):463-469. doi: 10.1016/j.bbamcr.2017.12.001. Epub 2017 Dec 6. Biochim Biophys Acta Mol Cell Res. 2018. PMID: 29223474 Review.
Cited by
-
Activated PyK2 and Its Associated Molecules Transduce Cellular Signaling from the Cancerous Milieu for Cancer Metastasis.Int J Mol Sci. 2022 Dec 7;23(24):15475. doi: 10.3390/ijms232415475. Int J Mol Sci. 2022. PMID: 36555115 Free PMC article. Review.
-
The Mystery of EVP4593: Perspectives of the Quinazoline-Derived Compound in the Treatment of Huntington's Disease and Other Human Pathologies.Int J Mol Sci. 2022 Dec 11;23(24):15724. doi: 10.3390/ijms232415724. Int J Mol Sci. 2022. PMID: 36555369 Free PMC article. Review.
-
ORAI Ca2+ Channels in Cancers and Therapeutic Interventions.Biomolecules. 2024 Mar 29;14(4):417. doi: 10.3390/biom14040417. Biomolecules. 2024. PMID: 38672434 Free PMC article. Review.
-
Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca2+ Signaling, and Glutamate.Front Cell Neurosci. 2021 Jun 2;15:663092. doi: 10.3389/fncel.2021.663092. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34149360 Free PMC article. Review.
References
-
- Heiss W-D. Contribution of PET imaging to clinical management of gliomas. OBM Neurobiol. 2018;2:1–1.
-
- Wirsching HG, Galanis E, Weller M. Glioblastoma. In: Handbook of clinical neurology. Vol. 134; 2016. p. 381–397. - PubMed
-
- Batash R, Asna N, Schaffer P, et al. Glioblastoma multiforme, diagnosis and treatment; Recent literature review. Curr Med Chem. 2017;24:3002–3009. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous